This paper reports on two patients with carcinoid tumours of the gall bladder who presented to the Aberdeen hospitals during the period 1970 to 1990 and reviews all previously reported cases in published works.
The carcinoid tumour or argentaffinoma originates from the Kultchitsky cell, which is believed to be derived from the neuroendocrine epiblast tissue. This migrates during embryogenesis to various endodermal or mesodermal tissue. ' Carcinoid tumours are capable of secreting a number of polypeptide substances and also decarboxylating amine precursors in preparation for secretion for example, histamine, serotonin, 5-hydroxytryptamine.2 3 They all share common cytochemical, ultrastructural, and biosynthetic properties.4
The carcinoid tumour may arise from the appendix (35%), small bowel (25%), colon and rectum (19%), oesophagus and stomach (2%), and lungs and bronchi (14% A 51 year old woman presented with a two month history of right hypochondrial, colicky pain, radiating to her back, associated with fat intolerance. Pre-operative imaging investigations showed cholelithiasis and cholecystectomy was subsequently performed. Pathological examination of the gall bladder showed chronic cholecystitis and a carcinoid tumour, 2 6 mm in diameter, at the gall bladder neck (Fig 1) . The tumour affected the mucosa and had infiltrated into the muscularis mucosa but had been completely excised. Histologically, it was composed of trabeculae, cords, and nests of banal polygonal cells. The gastrointestinal tract and atypical carcinoid tumour of the lung, both of which behave more aggressively than the classic form. All the variants possess metastatic potential, however, which is not only dependent on the site of origin but also the size of the primary lesion and its depth of invasion. The bland cytological morphology does not allow a prediction of metastatic potential to be made from histological appearances.
Primary gall bladder and biliary duct system carcinoids comprise less than 1% of all carcinoid tumours arising from any tissue or organ in the body.2 The first case ofprimary carcinoid tumour of the gall bladder was reported by Joel in 1929,12 and since then a further 24 cases have been described. (Tables I and II) . From the published data and our two patients, the age at presentation has ranged from 26-79 years (median: 64 years). There were 17 women and eight men, two further case reports did not give details of the patient's sex. Figure 3 outlines the incidence v age for each sex. The mode of presentation has varied considerably, but most cases (16) were detected coincidentally in patients presenting with acute or chronic cholecystitis secondary to cholelithiasis. The tumours were usually identified at routine histological examination of the gall bladder after cholecystectomy. The size or proximity of the tumour to the hepatic ducts has been responsible for mechanical obstruction and presentation as obstructive jaundice. Only two of the reported gall bladder carcinoids presented in this manner, whereas, one halfofthe documented carcinoid tumours of the extra hepatic ducts presented with obstructive jaundice.7 Furthermore, the carcinoid syndrome has been found in only two patients, both of whom had disseminated disease. 14 27 Pre-operative diagnosis of carcinoid tumour of the gall bladder is difficult, mainly because of its small size and limitations in the resolution of the currently available radiological imaging techniques. Nevertheless, 11 of 27 patients with gall bladder carcinoid tumours (including our two cases) had a pre-operative ultrasound examination. In seven of these patients a mass consistent with a carcinoid tumour was identified. Most of the tumours were undetected before surgery, however, and in the absence of other associated phenomena, such as the carcinoid syndrome (two cases), pre-operative diagnosis was not made.
The surgical treatment undertaken in these patients has varied, ranging from simple cholecystectomy to more extensive surgical resections, including regional lymph node clearances and hepatic lobectomy. Cholecystectomy alone was performed in 14 patients and a further four patients had, in addition to cholecystectomy, a regional lymph node clearance. Four other patients had cholecystectomy combined with hepatic lobectomy, for locally advanced disease.
The role of radiotherapy and chemotherapy in the management of these patients is unclear because it is believed that, in general, carcinoid tumours are insensitive to radiotherapy. Chemo From the published work, including our two case reports, overall survival data have been documented for 18 of 27 patients. Ten patients were known to be alive at the time of reporting and patient follow up has ranged from 0 to 184 months. The median survival of all patients is 11 months, but it is interesting to note that this was longer in men than women (18 v 12 months), although further follow up data are required. The addition of chemotherapy or radiotherapy, or both did not change survival. All the patients who received either chemotherapy or radiotherapy or both were dead within 35 months from the time of the original diagnosis.
